Pharma Mar SA - Company Profile
Powered by 
All the sales intelligence you need on Pharma Mar SA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Pharma Mar SA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Pharma Mar SA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Pharma Mar SA patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230390285A1 | Application | Lurbinectedin composition and methods making the same | A61K31/4738; A61K31/4745; A61K31/4995; A61K31/573; A61K38/193; A61K9/0019; A61P11/00; A61P35/00; C07B2200/13; C07D519/00 | December 07, 2023 |
| US20230390286A1 | Application | Method of treating sclc and managing thrombocytopenia | A61K31/4738; A61K31/4745; A61K31/4995; A61K31/573; A61K38/193; A61K9/0019; A61P11/00; A61P35/00; C07B2200/13; C07D519/00 | December 07, 2023 |
| RS64727B1 | Grant | Anticancer compounds | A61K31/427; A61K31/4439; A61K31/5377; A61K31/661; A61K31/7048; A61K31/7056; A61P35/00; C07D413/12; C07D417/12; C07D417/14; C07D493/04; C07D493/14; C07F9/141; C07H15/26; C07H19/24 | November 30, 2023 |
| RS64686B1 | Grant | Antitumoral compounds | A61K31/4995; A61P35/00; C07B2200/07; C07D515/22; Y02P20/55 | November 30, 2023 |
| CA3117268C | Grant | Antibody drug conjugates comprising ecteinascidin derivatives | A61K2039/505; A61K31/4995; A61K47/6803; A61K47/6851; A61K47/6855; A61K47/6889; A61P35/00; C07K16/2896; C07K16/32 | November 21, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer